FX.co ★ Becton, Dickinson Boosts FY24 Outlook; Boosts Dividend 9.5% - Update

In its fourth-quarter financial report released on Thursday, the medical technology firm Becton, Dickinson and Co. (BDX) has upgraded its adjusted earnings and revenue forecast for the fiscal year 2024.

For 2024, Becton, Dickinson now envisions adjusted earnings ranging from $14.25 to $14.60 per share, alongside projected revenues between $21.9 billion and $22.1 billion. This forecast includes an anticipated organic revenue growth between 4.0% and 4.5%.

Previously, the company's financial outlook included adjusted earnings between $13.05 and $13.15 per share, with expected revenues of $20.1 billion to $20.2 billion and organic revenue growth of 5.0% to 5.25%.

Analysts surveyed by Thomson Reuters anticipate the company will report earnings of $13.11 per share, accompanied by a revenue growth estimate of 4.1%, reaching approximately $20.16 billion for the year. These analyst projections typically do not factor in special items.

Additionally, the Board of Directors of Becton, Dickinson has announced a 9.5% increase in its quarterly dividend, raising it to $1.04 per common share. This dividend is scheduled for payment on December 31, 2024, to shareholders recorded by December 9, 2024.